GSK Targets 85 Percent Of World’s Smokers With Cessation Products

GlaxoSmithKline plans a big marketing expansion in the emerging markets of the world, particularly in China and India. The firm is leading with its smoking-cessation drugs, targeting 20 new markets as it seeks to increase sales in the developing world. GSK markets lozenges and patches to help smokers quit, but has not been marketing them heavily outside of the developed world. Current statistics indicate that most of the world's smokers live in developing nations only now mounting anti-smoking campaigns. GSK plans to reach 85 percent of the smokers in the world within five years. (Click here for more - a subscription may be required